Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Burkitt Lymphoma 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 3Down Syndrome 2Blast Crisis 2Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1HTLV-I Infections 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 24Cyclophosphamide 22Whole-Body Irradiation 18Mycophenolic Acid 16Cyclosporine 15Tacrolimus 12Busulfan 12Etoposide 11Antilymphocyte Serum 11Methotrexate 9Melphalan 9Bortezomib 9Rituximab 8Filgrastim 8Carboplatin 7Therapeutics 6Lenalidomide 6Everolimus 6Doxorubicin 6Vorinostat 5Radiotherapy 5Prednisone 5Flow Cytometry 5Alemtuzumab 5tanespimycin 4Vincristine 4Sirolimus 4Psychiatric Rehabilitation 4Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoblastic Lymphadenopathy × prednylidene × Other hematologic neoplasm × Clear all
NCT03113500 2025-11-14

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

City of Hope Medical Center

Phase 2 Active not recruiting
48 enrolled 8 charts
LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡